| scholarly article | Q13442814 |
| P2093 | author name string | P J Willems | |
| A Vereecken | |||
| D Bekedam | |||
| Es Vandenakker | |||
| H Dierickx | |||
| K Deboulle | |||
| N Segers | |||
| P2860 | cites work | Amniocentesis and chorionic villus sampling for prenatal diagnosis | Q24247990 |
| First-trimester screening for chromosomal abnormalities | Q36232056 | ||
| Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomy | Q36406163 | ||
| Twenty-year trends in the prevalence of Down syndrome and other trisomies in Europe: impact of maternal age and prenatal screening | Q36466446 | ||
| What is next generation sequencing? | Q37346079 | ||
| Cell-free fetal DNA and maternal serum analytes for monitoring embryonic and fetal status | Q38090127 | ||
| Clinical experience of noninvasive prenatal testing with cell-free DNA for fetal trisomies 21, 18, and 13, in a general screening population | Q38427300 | ||
| Implementation of maternal blood cell-free DNA testing in early screening for aneuploidies. | Q43418239 | ||
| Population screening for fetal trisomy 21: easy access to screening should be balanced against a uniform ultrasound protocol | Q50122850 | ||
| Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
| First-trimester screening for trisomies 21 and 18 | Q79133560 | ||
| The role of noninvasive prenatal testing as a diagnostic versus a screening tool--a cost-effectiveness analysis | Q86793691 | ||
| A new era in noninvasive prenatal testing | Q87109039 | ||
| P433 | issue | 1 | |
| P921 | main subject | Belgium | Q31 |
| Netherlands | Q55 | ||
| P304 | page(s) | 7-12 | |
| P577 | publication date | 2014-01-01 | |
| P1433 | published in | Facts, Views & Vision in ObGyn | Q26842058 |
| P1476 | title | The first 3,000 Non-Invasive Prenatal Tests (NIPT) with the Harmony test in Belgium and the Netherlands | |
| P478 | volume | 6 |
| Q37624999 | "I think we've got too many tests!": Prenatal providers' reflections on ethical and clinical challenges in the practice integration of cell-free DNA screening. |
| Q90376066 | A proof-of-concept study on the effects of low total cfDNA content and solutions to increase the NIPT trisomy 21 detection rate |
| Q36656349 | False Negative Cell-Free DNA Screening Result in a Newborn with Trisomy 13. |
| Q47618331 | Genomics-based non-invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women. |
| Q35729508 | Has Noninvasive Prenatal Testing (NIPT) Come of Age? |
| Q37472073 | NIPTRIC: an online tool for clinical interpretation of non-invasive prenatal testing (NIPT) results |
| Q36762710 | Noninvasive prenatal testing in the general obstetric population: clinical performance and counseling considerations in over 85 000 cases |
| Q53163552 | Patients' Knowledge of Prenatal Screening for Trisomy 21. |
| Q35649161 | Positive predictive value of non-invasive prenatal screening for fetal chromosome disorders using cell-free DNA in maternal serum: independent clinical experience of a tertiary referral center |
| Q35427976 | Screening Performance and Costs of Different Strategies in Prenatal Screening for Trisomy 21. |
| Q37558281 | Trial by Dutch laboratories for evaluation of non-invasive prenatal testing. Part I-clinical impact |
| Q35763064 | Unexplained False Negative Results in Noninvasive Prenatal Testing: Two Cases Involving Trisomies 13 and 18. |
Search more.